NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/07/2025
Voltar para busca
Dado oficial do USPTO
HERVOLUTION
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
HERVOLUTION
ST13
US500000098393796Classe
5, 35, 42
Pedido
98393796
Registro
7854817
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
21
Atualização mais recente
03/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 35, 42
Data de depósito
06/02/2024
Data de registro
08/07/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
08/07/2025
Última transação
03/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
99
Localização do titular
Copenhagen, DK
Examinador
AVENT, TEAGUE A
Unidade examinadora
N80
Localização atual
TMO LAW OFFICE 126
Titulares e representantes
Titulares
I. A. (pessoa física)
Representantes
Margaret C. McHugh Kilpatrick Townsend & Stockton LLP
Classificação técnica
Classes Nice
Classe 5Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceuticals for immunotherapy and cancer therapy; medical and veterinary preparations for treating immune diseases and cancer; Substances adapted for medical or veterinary usenamely pharmaceutical preparations for treating immune diseases and cancer; Vaccines and medicines for the treatment of cancerimmune diseasesneurodegenerative diseasesAlzheimer's diseaseParkinson's diseaseHuntington's diseaseamyotrophic lateral sclerosis (ALS)senescence associated diseases being age-related conditionsfrailtyosteoporosisliver steatosiscognitive decline; Viral-based immunotherapeutics being pharmaceutical preparationsin particular for the treatment of cancerimmune diseasesneurodegenerative diseasesAlzheimer's diseaseParkinson's diseaseHuntington's diseaseALSsenescence associated diseases being age-related conditionsfrailtyosteoporosisliver steatosiscognitive decline
Classe 35
Business managementorganization and administration; business management of licences for pharmaceuticalsvaccines and medicinessuch as viral-based immunotherapeuticsin particular for the treatment of cancerimmune diseasesdegenerative diseases and senescence associated diseases; import and export agency services in the field of pharmaceuticalsvaccines and medicinessuch as viral-based immunotherapeuticsin particular for the treatment of cancerimmune diseasesdegenerative diseases and senescence associated diseases; retail store and wholescale store servicesonline retail store and wholesale store servicesin the field of pharmaceuticalsvaccines and medicinessuch as viral- based immunotherapeuticsin particular for the treatment of cancerimmune diseasesdegenerative diseases and senescence associated diseases
Classe 42
Research and development of pharmaceuticalsvaccines and medicinessuch as viral-based immunotherapeuticsin particular for the treatment of cancerimmune diseasesdegenerative diseases and senescence associated diseases; conducting clinical trials of others in the field of pharmaceuticalsvaccines and medicinessuch as viral-based immunotherapeuticsin particular for the treatment of cancerimmune diseasesdegenerative diseases and senescence associated diseases; medicalbiologicalscientific research relating to the treatment of cancerimmune diseasesdegenerative diseases and senescence associated diseasesin particular via immunotherapy
Publicações
Histórico de despachos e eventos da marca no USPTO.
21 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
08/07/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/05/2025
PUBO
PUBLISHED FOR OPPOSITION
20/05/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
14/05/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/04/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/04/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/04/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
14/04/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
22/01/2025
GNFR
FINAL REFUSAL E-MAILED
22/01/2025
CNFR
FINAL REFUSAL WRITTEN
22/01/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/11/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/11/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/11/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
30/08/2024
GNRT
NON-FINAL ACTION E-MAILED
30/08/2024
CNRT
NON-FINAL ACTION WRITTEN
30/08/2024
DOCK
ASSIGNED TO EXAMINER
30/08/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/06/2024
NWAP
NEW APPLICATION ENTERED
06/02/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HERVOLUTION ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.